![FibroGen Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/fgen.png?tr=w-200)
FibroGen Inc
NASDAQ:FGEN
![FibroGen Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/fgen.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/fgen.png)
FibroGen Inc
Stock-Based Compensation
FibroGen Inc
Stock-Based Compensation Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/gild.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/amgn.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/vrtx.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/regn.png)
Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors
Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
FibroGen Inc
NASDAQ:FGEN
|
Stock-Based Compensation
$43.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
26%
|
![]() |
Abbvie Inc
NYSE:ABBV
|
Stock-Based Compensation
$782m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
Stock-Based Compensation
$788m
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
11%
|
![]() |
Amgen Inc
NASDAQ:AMGN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Stock-Based Compensation
$650.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is FibroGen Inc's Stock-Based Compensation?
Stock-Based Compensation
43.4m
USD
Based on the financial report for Mar 31, 2024, FibroGen Inc's Stock-Based Compensation amounts to 43.4m USD.
What is FibroGen Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
26%
Over the last year, the Stock-Based Compensation growth was -33%. The average annual Stock-Based Compensation growth rates for FibroGen Inc have been -17% over the past three years , -6% over the past five years , and 26% over the past ten years .